Skip to main content

Table 4 Rate of change in secondary endpoints

From: The effectiveness in preventing frailty of exercise intervention provided by community pharmacists to older persons with chronic conditions: A pragmatic randomized controlled trial

Secondary evaluation items

sex

Group

n

Mean

95% CI

 

Body weight

M

IG

25

-1.07%

-0.54% ~ -1.59%

 

UG

13

-1.93%

-1.16% ~ -2.70%

 

F

IG

21

-1.15%

-0.75% ~ -1.55%

 

UG

11

-4.94%

-3.55% ~ -6.32%

 

Body fat percentage

M

IG

25

-0.07%

-0.09% ~ -0.05%

 

UG

13

-0.07%

-0.04% ~ -0.09%

 

F

IG

21

-0.02%

-0.03% ~ -0.01%

 

UG

11

-0.08%

-0.05% ~ -0.10%

 

BMI

M

IG

25

-0.02%

-0.03% ~ -0.03%

 

UG

13

-0.02%

-0.02% ~ -0.03%

 

F

IG

21

0.00%

-0.01% ~ -0.001%

 

UG

11

-0.04%

-0.03% ~ -0.06%

 

Estimated bone mass

M

IG

25

-0.01%

-0.02% ~ 0.00%

 

UG

13

0.00%

-0.01% ~ 0.01%

 

F

IG

21

0.00%

-0.01% ~ 0.01%

 

UG

11

-0.02%

-0.03% ~ -0.01%

 

Body water content

M

IG

25

0.04%

0.03% ~ 0.05%

 

UG

13

0.02%

0.01% ~ 0.04%

 

F

IG

21

0.02%

0.01% ~ 0.04%

 

UG

11

0.05%

0.03% ~ 0.07%

 
  1. IG : Intervention Group UG : Usual Care Group